Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5842048 | 0.88 | DRD2 (0.41) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL9270 | 0.85 | TSHR (0.46) | SLC6A4TSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL177637 | 0.81 | ACHE (0.52) | DRD2DRD4DRD3MAPTTSHR | |
| SCHEMBL5841039 | 0.77 | CA12 (0.41) | MAPTSMN1; SMN2NPC1RAB9AMEN1 | |
| SCHEMBL172615 | 0.75 | HTR2A (0.55) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL28604976 | 0.74 | HTR2A (0.53) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL2310163 | 0.72 | ALDH1A1 (0.41) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL27819241 | 0.71 | DRD2 (0.45) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL27819167 | 0.71 | DRD2 (0.45) | DRD2DRD4DRD3HTR2ASLC6A4 | |
| SCHEMBL363120 | 0.71 | ACHE (0.52) | DRD2DRD4DRD3RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3140007-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | Apicore US LLC (US) | 2017-03-15 | — | — | EP | claimed |
| US-20160368875-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | MYLAN API US LLC | 2016-12-22 | — | — | US | claimed |
| WO-2015171489-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | APICORE US LLC (US) | 2015-11-12 | — | — | WO | claimed |
| US-20150315149-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | MYLAN API US LLC | 2015-11-05 | — | — | US | claimed |
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| US-20260109131-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | PROCTER & GAMBLE (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | PROCTER & GAMBLE (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4638687-A2 | DETERGENT COMPOSITION COMPRISING CATALASE AND AMYLASE | Novozymes A/S (DK) | 2025-10-29 | — | — | EP | disclosed |
| EP-4634219-A1 | HIGH STRENGTH LIQUID PROTEASE FORMULATIONS | Novozymes A/S (DK) | 2025-10-22 | — | — | EP | disclosed |
| US-20250295120-A1 | CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION | NOVOZYMES A/S (DK) | 2025-09-25 | — | — | US | disclosed |
| US-20250129307-A1 | Microencapsulation Using Amino Sugar Oligomers | NOVOZYMES A/S (DK) | 2025-04-24 | — | — | US | disclosed |
| WO-2025073833-A1 | OPTIMIZED PROCESS FOR THE PREPARATION OF IOPAMIDOL | BRACCO IMAGING SPA (IT) | 2025-04-10 | — | — | WO | disclosed |
| EP-1144388-A1 | ACYL DERIVATIVES WHICH TREAT VLA-4 RELATED DISORDERS | Elan Pharmaceuticals, Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000043372-A1 | ACYL DERIVATIVES WHICH TREAT VLA-4 RELATED DISORDERS | ELAN PHARMACEUTICALS, INC. (US) | 2000-07-27 | — | — | WO | disclosed |
| US-5880188-A | PROTECTING MEDIUM SUSCEPTIBLE TO MICROBIAL ATTACK BY TREATING WITH SPECIFIED OXABOROLE COMPOUND | ZENECA LIMITED (GB) | 1999-03-09 | — | — | US | disclosed |
| EP-0873123-A4 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIV PITTSBURGH (US) | 1999-02-03 | — | — | EP | disclosed |
| EP-0873123-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-10-28 | — | — | EP | disclosed |
| WO-1997017070-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1997-05-15 | — | — | WO | disclosed |
| EP-0765331-A1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | ZENECA LIMITED (GB) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995033754-A1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | ZENECA LIMITED (GB) | 1995-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160368875-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | NMUR1, NNT, NMUR2 | DRD2 1441/4885DRD4 1570/4885DRD3 1852/4885 |
| US-20250295120-A1 | CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION | DNASE1, HEXD, HEXA | DRD2 1959/4885DRD4 1665/4885DRD3 2278/4885 |
| US-20260109131-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | VCAM1, PLOD3, TLN1 | DRD2 2315/4885DRD4 2357/4885DRD3 2283/4885 |
| US-20150315149-A1 | METHODS OF MAKING NETUPITANT AND INTERMEDIATES THEREOF | NMUR1, NNT, NMUR2 | DRD2 1441/4885DRD4 1570/4885DRD3 1852/4885 |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | VCL, PLOD3, ILK | DRD2 2837/4885DRD4 3034/4885DRD3 2556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.